In summary, the QHF has a clear effect on improving NASH liver injury, and its mechanism is related to upregulation of SOCS1 expression to inhibit the activation of the TLR4/NF-κB signaling pathway. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.